½ÃÀ庸°í¼­
»óǰÄÚµå
1359027

IoT ÀÇ·á±â±â ½ÃÀå ¿¹Ãø(-2030³â) : Á¦Ç°º°, À¯Çüº°, Á¢¼Ó ±â¼úº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¼¼°è ºÐ¼®

IoT Medical Devices Market Forecasts to 2030 - Global Analysis By Product, Type, Connectivity Technology, Application, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ IoT ÀÇ·á±â±â ½ÃÀåÀº 2023³â¿¡ 501¾ï ´Þ·¯¸¦ Â÷ÁöÇÏ°í ¿¹Ãø ±â°£ Áß CAGRÀº 27.5%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 2,741¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

ÇコÄÉ¾î »ê¾÷ÀÇ IoT ÀÇ·á±â±â ½ÃÀåÀº »ç¹°ÀÎÅͳÝ(IoT) ±â¼úÀ» Ȱ¿ëÇÑ »óÈ£ ¿¬°áµÈ ÀÇ·á±â±âÀÇ °³¹ß°ú Ȱ¿ë¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí °Ç°­ ÃßÀû±â, ¿ø°Ý ¸ð´ÏÅ͸µ ½Ã½ºÅÛ, ½º¸¶Æ® ÀÇ·á±â±â µîÀ» Æ÷ÇÔÇÑ ÀÌ·¯ÇÑ ±â±â´Â ½Ç½Ã°£ ȯÀÚ µ¥ÀÌÅ͸¦ ¼öÁý, Àü¼Û ¹× ºÐ¼®ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¼¼°èÀ̵¿Åë½Å»ç¾÷ÀÚ¿¬ÇÕȸ(GSMA)¿¡ µû¸£¸é 2020³â ¸»±îÁö ¼¼°è ½º¸¶Æ®Æù º¸±Þ·üÀÌ ¸ð¹ÙÀÏ ¿¬°á¿¡¼­ Â÷ÁöÇÏ´Â ºñÁßÀº 67%¿¡ ´ÞÇϰí, 2025³â¿¡´Â 70%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. 54¾ïÀ» µ¹ÆÄÇÏ¿© 44¾ï ¸íÀÌ ¸ð¹ÙÀÏ ÀÎÅͳÝÀ» ÀÌ¿ëÇÏ°Ô µÉ °ÍÀÔ´Ï´Ù.

µðÁöÅÐ Çコ Ȱ¼ºÈ­¸¦ À§ÇÑ Á¤ºÎÀÇ ±¸»ó

¼¼°èÀÇ ¸¹Àº Á¤ºÎ´Â ÀÇ·á Á¢±Ù¼ºÀ» °³¼±Çϰí, ºñ¿ëÀ» Àý°¨Çϸç, ȯÀÚ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ´Â IoT ÀÇ·á±â±âÀÇ ÀáÀç·ÂÀ» ÀνÄÇϰí ÀÖ½À´Ï´Ù. À̵é Á¤ºÎ´Â ÀÇ·á ½Ã½ºÅÛ¿¡¼­ ÀÌ·¯ÇÑ ±â±âÀÇ Ã¤ÅÃÀ» Àå·ÁÇϱâ À§ÇØ Á¤Ã¥, ±ÔÁ¦ ¹× Á¤Ã¥, ÀÚ±Ý Áö¿ø ÇÁ·Î±×·¥À» ½ÃÇàÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áö¿ø¿¡´Â »óȯ Á¦µµ, ¿ø°ÝÀÇ·á ±ÔÁ¦, »óÈ£¿î¿ë¼º ¹× µ¥ÀÌÅÍ º¸¾ÈÀ» À§ÇÑ ±¸»óÀÌ Æ÷ÇԵ˴ϴÙ. ±× °á°ú, IoT ÀÇ·á±â±â Á¦Á¶¾÷ü¿Í ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â ÀÌ·¯ÇÑ ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ¿Í Ã¤ÅÃÀ» Á¡Á¡ ´õ ¸¹ÀÌ Àå·ÁÇϰí ÀÖ½À´Ï´Ù.

¿¬°áÇü ÀÇ·á±â±âÀÇ ³ôÀº µµÀÔºñ¿ë

IoT ±â¼úÀ» ÀÇ·á ÀÎÇÁ¶ó¿¡ ÅëÇÕÇÏ·Á¸é Àåºñ Á¶´Þ, µ¥ÀÌÅÍ °ü¸®, »çÀ̹ö º¸¾È ´ëÃ¥¿¡ ¸¹Àº ÅõÀÚ°¡ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ºñ¿ëÀº ƯÈ÷ ¼Ò±Ô¸ð ÀÇ·á ½Ã¼³À̳ª ÀÚ¿øÀÌ ºÎÁ·ÇÑ Áö¿ª¿¡¼­´Â À庮ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Áö¼ÓÀûÀÎ À¯Áöº¸¼ö ¹× ¾÷µ¥ÀÌÆ®´Â ÃÑ ¼ÒÀ¯ºñ¿ëÀ» ´õ¿í Áõ°¡½Ã۸ç, IoT ÀÇ·á±â±â´Â Àå±âÀûÀ¸·Î ȯÀÚ Ä¡·á °³¼± ¹× ÀÇ·áºñ Àý°¨ µî Å« ÀÌÁ¡À» °¡Á®´ÙÁÖÁö¸¸ Ãʱ⠰æÁ¦Àû ºÎ´ãÀº º¸±Þ¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

°í¼Ó ³×Æ®¿öÅ© ±â¼úÀÇ ÁøÈ­

5G, ÀúÁö¿¬ ¹× ±¤´ë¿ª ³×Æ®¿öÅ© µîÀÇ ¹ßÀüÀ¸·Î ÀÇ·á±â±â¿Í ÀÇ·á ½Ã½ºÅÛ °£ÀÇ ¿øÈ°ÇÑ ½Ç½Ã°£ Åë½ÅÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ÀÌ´Â ÀÇ·á ºÐ¾ßÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ, ¿ø°ÝÀÇ·á ¹× µ¥ÀÌÅÍ Áý¾àÀû ¿ëµµ¿¡ »õ·Î¿î °¡´É¼ºÀ» ¿­¾îÁÝ´Ï´Ù. ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â ȯÀÚ µ¥ÀÌÅÍ¿¡ ½Å¼ÓÇϰí Á¤È®ÇÏ°Ô Á¢±ÙÇÒ ¼ö ÀÖÀ¸¸ç, Áø´ÜÀÇ Á¤È®¼º°ú Ä¡·á °èȹÀ» °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ °í¼Ó ³×Æ®¿öÅ·Àº ÀÇ·á µ¥ÀÌÅÍÀÇ ¾ÈÀüÇϰí È¿À²ÀûÀÎ Àü¼ÛÀ» ¿ëÀÌÇÏ°Ô Çϰí, ȯÀÚÀÇ ÇÁ¶óÀ̹ö½Ã¿Í ±ÔÁ¦ Áؼö¸¦ º¸ÀåÇÕ´Ï´Ù.

µ¥ÀÌÅÍ °ü¸® ¹× »óÈ£¿î¿ë¼º °ü·Ã ¹®Á¦

Á¼® ÀÛµ¿ ½Ã½ºÅÛ°ú ¿Ïº®ÇÏ°Ô ÅëÇÕµÈ »ç¿ëÀÚ Ä£È­ÀûÀ̰í ÀÎü°øÇÐÀûÀÎ PCU¸¦ °³¹ßÇÏ´Â °ÍÀº º¹ÀâÇÑ °úÁ¦ÀÔ´Ï´Ù. Á÷°üÀûÀÎ Á¶ÀÛ, ¾ÈÀü ±â´É ¹× Àüü ±â³» µðÀÚÀΰúÀÇ È£È¯¼ºÀ» º¸ÀåÇϱâ À§Çؼ­´Â ¿£Áö´Ï¾î¸µ Àü¹® Áö½ÄÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¶ÇÇÑ ¾ö°ÝÇÑ Ç×°ø ±ÔÁ¤°ú ÀÎÁõ ÀýÂ÷´Â Á¦Á¶¾÷ü¿¡ ¶Ç ´Ù¸¥ µµÀü °úÁ¦¸¦ ¾È°ÜÁÖ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¦¾àÀ» ±Øº¹Çϱâ À§Çؼ­´Â ¾ÈÀü ¹× ±ÔÁ¤ Áؼö Ç¥ÁØÀ» ÈѼÕÇÏÁö ¾ÊÀ¸¸é¼­ ½Â°´ÀÇ Àü¹ÝÀûÀÎ °æÇèÀ» Çâ»ó½ÃŰ´Â È¿À²ÀûÀÌ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â PCU¸¦ °³¹ßÇϱâ À§ÇØ R&D¿¡ ÅõÀÚÇØ¾ß ÇÕ´Ï´Ù.

COVID-19ÀÇ ¿µÇâ :

ÇコÄÉ¾î »ê¾÷Àº ÀÌ Àü·Ê ¾ø´Â ¼¼°è ÆÒµ¥¹Í ¹®Á¦ÀÇ ÃÖÀü¼±¿¡ ÀÖÀ¸¹Ç·Î COVID-19ÀÇ ¿µÇâÀ» Á÷Á¢ÀûÀ¸·Î ¹Þ°í ÀÖÀ¸¸ç, COVID-19ÀÇ ¹ß»ýÀ¸·Î ÀÎÇØ IoMT Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ ºü¸£°Ô Áõ°¡ÇÏ¿© ¼¼°è ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¿ëµµ°ú ±âȸ°¡ Áõ°¡ÇÔ¿¡ µû¶ó Àü¿°º´Àº µðÁöÅÐ Çõ½ÅÀÇ Ã˸ÅÁ¦ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. Á¤ºÎ ±â°ü, ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ ¹× »ç¶÷µéÀº ¸ðµÎ ±× °á°ú ¿ì¼±¼øÀ§¸¦ Á¶Á¤Çϰųª º¯°æÇØ¾ß ÇÕ´Ï´Ù. Àü¿°º´ÀÌ °¡Á®¿Â Á¦¾à¿¡µµ ºÒ±¸Çϰí, ¿¬°áµÈ °¡Á¬À» ÅëÇØ »ç¶÷µéÀº ÀÚ½ÅÀÇ °Ç°­À» ¸ð´ÏÅ͸µÇϰí, °¡»ó Áø´ÜÀ» ¹Þ°í, ´õ È¿°úÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

¿¹Ãø ±â°£ Áß È°·Â¡ÈÄ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ºÐ¾ß°¡ °¡Àå Å« ½ÃÀåÀ¸·Î ºÎ»óÇÒ Àü¸Á

½É¹Ú¼ö, Ç÷¾Ð, ü¿Â, »ê¼Ò ¼öÁذú °°Àº Çʼö »ý¸®Àû ¸Å°³ º¯¼ö¸¦ ½Ç½Ã°£À¸·Î ÃßÀûÇÏ°í ºÐ¼®ÇÏ´Â »ýü ½ÅÈ£ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ºÐ¾ß°¡ À¯¸ÁÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ IoT ±â±â´Â ÀÓ»ó ȯ°æ°ú °¡Á¤ ¸ðµÎ¿¡¼­ ȯÀÚ¸¦ Áö¼ÓÀûÀ¸·Î ¿ø°ÝÀ¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖÀ¸¸ç, ÀÇ·á Àü¹®°¡¿¡°Ô Áß¿äÇÑ µ¥ÀÌÅÍ¿¡ ´ëÇÑ Áï°¢ÀûÀÎ ¾×¼¼½º¸¦ Á¦°øÇÕ´Ï´Ù. Áúº´ÀÇ Á¶±â ¹ß°ß, ¸¸¼ºÁúȯ °ü¸®, ¼ö¼ú ÈÄ Ä¡·á¿¡ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ¿© ȯÀÚÀÇ °á°ú¸¦ °³¼±ÇÏ°í º´¿ø ÀçÀÔ¿øÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù.

Á¤ÂøÇü ÀÇ·á±â±â ºÐ¾ß´Â ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»ó

Á¤ÂøÇü ÀÇ·á±â±â ºÐ¾ß´Â ¿¹Ãø ±â°£ Áß °¡Àå ºü¸¥ CAGR ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, IoT ±â¼ú°ú ÅëÇÕµÈ ÀÌ ±â±âµéÀº ½Ç½Ã°£ ¸ð´ÏÅ͸µ, µ¥ÀÌÅÍ ¼öÁý ¹× ȯÀÚ Á¤º¸ÀÇ ¿ø°Ý °ü¸®¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î IoT·Î ¿¬°áµÈ MRI Àåºñ, ¿¢½º·¹ÀÌ Àåºñ, °Ë»ç ºÐ¼® Àåºñ µîÀÌ ÀÖ½À´Ï´Ù. À̵éÀº µ¥ÀÌÅÍ Àü¼ÛÀ» °£¼ÒÈ­Çϰí Áø´Ü Á¤È®µµ¸¦ ³ôÀ̸ç ÀÇ·á Àü¹®°¡°¡ ȯÀÚ¸¦ º¸´Ù È¿À²ÀûÀ¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. °íÁ¤Çü ÀÇ·á±â±â´Â Ä¡·á Á¤È®µµ Çâ»ó ¹× ÀÎÀû ¿À·ù °¨¼Ò¿Í °°Àº ÀÌÁ¡À» Á¦°øÇÏ¿© ȯÀÚ °á°ú¸¦ °³¼±ÇÏ°í ½Ã¼³³» ÀÇ·á ¼­ºñ½º Á¦°øÀÇ Àü¹ÝÀûÀÎ È¿À²¼ºÀ» Çâ»ó½ÃŰ´Â µ¥ ±â¿©ÇÕ´Ï´Ù.

°¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª

ºÏ¹Ì´Â ÷´ÜÈ­µÈ ÀÇ·á ÀÎÇÁ¶ó, °­·ÂÇÑ R&D ¿ª·®, Áö¿øÀûÀÎ ±ÔÁ¦ ȯ°æÀ¸·Î ÀÎÇØ IoT ÀÇ·á±â±â ½ÃÀå¿¡¼­ Å« ºñÁßÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀÌ È¯ÀÚ Ä¡·á¿Í °á°ú °³¼±À» À§ÇØ ¿þ¾î·¯ºí °Ç°­ ÃßÀû±â, ¿ø°Ý ¸ð´ÏÅ͸µ ½Ã½ºÅÛ µî IoT ±â¹Ý ÀÇ·á±â±â µµÀÔ·üÀÌ ³ôÀº Áö¿ªÀÔ´Ï´Ù. ºÏ¹Ì´Â ¿ø°ÝÀÇ·á¿Í µ¥ÀÌÅͺ£À̽º ÀÇ·á¿¡ ´ëÇÑ ÅõÀÚ¿Í È¯ÀÚ Á᫐ ÀÇ·á ¸ðµ¨¿¡ ´ëÇÑ ÁýÁßÀûÀÎ ÅõÀÚ·Î IoT ±â¼úÀ» Ȱ¿ëÇØ ÀÇ·á ¼­ºñ½º Á¦°øÀ» Çõ½ÅÇÏ°í °­È­ÇÏ´Â ¼±µÎÁÖÀÚ·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª :

¾Æ½Ã¾ÆÅÂÆò¾çÀº Àα¸ Áõ°¡, ÀÇ·á ¼ö¿ä Áõ°¡, µðÁöÅÐ ±â¼ú äÅà Áõ°¡·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¤ºÎ ±¸»óÀÇ Áö¿ø°ú ±â¼ú¿¡ Á¤ÅëÇÑ ¼ÒºñÀÚÃþ Áõ°¡·Î ÀÎÇØ IoT ÀÇ·á±â±â´Â ºü¸£°Ô ¼ö¿ëµÇ°í ÀÖÀ¸¸ç, IoT ÀÇ·á±â±â´Â ȯÀÚ Ä¡·áÀÇ °³¼±°ú ´õºÒ¾î ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ°ú °°Àº °úÁ¦¸¦ ÇØ°áÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¹æ´ëÇÑ ½ÃÀå ÀáÀç·Â°ú ÇコÄɾî Çõ½Å¿¡ ´ëÇÑ Çå½ÅÀº ¼¼°è IoT ÀÇ·á±â±â ½ÃÀå¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ÀÇ·á ¼­ºñ½º Á¦°ø¿¡ ÀÖÀ¸¸ç, Çõ½ÅÀûÀÎ ¹ßÀüÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¹«·á ¸ÂÃãÇü ¼­ºñ½º

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÇü ¿É¼Ç Áß Çϳª¸¦ ÀÌ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. :

  • ±â¾÷ °³¿ä
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀû ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3»ç)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(ÃÖ´ë 3»ç)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ µû¸¥ ÁÖ¿ä ±¹°¡º° ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø, CAGR(Âü°í : Ÿ´ç¼º È®Àο¡ µû¶ó ´Ù¸§)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¿ªÀû ÀÔÁö, Àü·«Àû Á¦ÈÞ¸¦ ±â¹ÝÀ¸·Î ÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç ¾îÇÁ·ÎÄ¡
  • Á¶»ç ¼Ò½º
    • 1Â÷ Á¶»ç ¼Ò½º
    • 2Â÷ Á¶»ç ¼Ò½º
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • Á¦Ç° ºÐ¼®
  • ±â¼ú ºÐ¼®
  • ¾ÖÇø®ÄÉÀÌ¼Ç ºÐ¼®
  • ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ IoT ÀÇ·á±â±â ½ÃÀå : Á¦Ç°º°

  • ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ
    • Ç÷¾Ð°è
    • Ç÷´ç ¸ð´ÏÅÍ
    • ECG/½É¹Ú¼ö ¸ð´ÏÅÍ
    • »ê¼Ò ³óµµ°è
    • ¸ÖƼÆÄ¶ó¹ÌÅÍ ¸ð´ÏÅÍ
  • À̹Ì¡ ½Ã½ºÅÛ
  • »ðÀÔÇü ½ÉÀå ±â±â
    • »ðÀÔÇü Á¦¼¼µ¿±â
    • »ðÀÔÇü ½ÉÀå ¸ð´ÏÅÍ
  • ȯÀÚ ¸ð´ÏÅÍ
  • È£Èí±â ±â±â
  • ÁÖÀÔ ÆßÇÁ
  • ÅÂ¾Æ ¸ð´ÏÅ͸µ ±â±â
  • ½Å°æ µð¹ÙÀ̽º
  • ÀΰøÈ£Èí±â
  • ¸¶Ãë±â
  • º¸Ã»±â
  • ±âŸ Á¦Ç°

Á¦6Àå ¼¼°èÀÇ IoT ÀÇ·á±â±â ½ÃÀå : À¯Çüº°

  • ¿þ¾î·¯ºí
  • »ðÀÔÇü µð¹ÙÀ̽º
  • °íÁ¤Çü ÀÇ·á±â±â
  • ±âŸ À¯Çü

Á¦7Àå ¼¼°èÀÇ IoT ÀÇ·á±â±â ½ÃÀå : Á¢¼Ó ±â¼úº°

  • Wi-Fi
  • ºí·çÅõ½º(Bluetooth)
  • Áö±×ºñ
  • ±âŸ Á¢¼Ó Å×Å©³î·¯Áö

Á¦8Àå ¼¼°èÀÇ IoT ÀÇ·á±â±â ½ÃÀå : ¿ëµµº°

  • ¿ø°ÝÀÇ·á
  • º¹¾à °ü¸®
  • ȯÀÚ ¸ð´ÏÅ͸µ
  • ±âŸ ¿ëµµ

Á¦9Àå ¼¼°èÀÇ IoT ÀÇ·á±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ÇコÄɾî ÇÁ·Î¹ÙÀÌ´õ
  • Á¤ºÎ±â°ü
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦10Àå ¼¼°èÀÇ IoT ÀÇ·á±â±â ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷, ÇÕº´»ç¾÷
  • ÀμöÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦12Àå ±â¾÷ °³¿ä

  • Honeywell Life Care Solutions
  • IBM Corporation
  • iHealth Lab
  • Cerner Corporation
  • Cisco Inc
  • GE Healthcare
  • Stanley Healthcare
  • Welch Allyn
  • Abbott Laboratories
  • AdhereTech
  • AgaMatrix
  • AliveCor
  • BioTelemetry
  • Biotronik
  • Boston Scientific
  • Capsule Technologies, Inc
  • Siemens
  • Medtronic
  • Meru Health
  • Omron
  • Philips
  • SAP affiliate company
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • LifeFuels Inc
KSA 23.10.24

According to Stratistics MRC, the Global IoT Medical Devices Market is accounted for $50.1 billion in 2023 and is expected to reach $274.1 billion by 2030 growing at a CAGR of 27.5% during the forecast period. The IoT Medical Devices Market in the healthcare industry is focused on the development and utilization of interconnected medical devices that leverage Internet of Things (IoT) technology. These devices, including wearable health trackers, remote monitoring systems, and smart medical equipment, enable the collection, transmission, and analysis of real-time patient data.

According to the Global System for Mobile Communications (GSMA), global smartphone adoption, as a percentage of mobile connections, reached 67% by the end of 2020 and is projected to reach 70% by 2025. By the end of 2022, global mobile service subscriptions surpassed 5.4 billion, with 4.4 billion individuals using mobile internet.

Market Dynamics:

Driver:

Government initiatives to promote digital health

Many governments worldwide are recognizing the potential of IoT medical devices to improve healthcare accessibility, reduce costs, and enhance patient outcomes. They are implementing policies, regulations, and funding programs to incentivize the adoption of these devices in healthcare systems. This support includes reimbursement schemes, telemedicine regulations, and initiatives for interoperability and data security. As a result, IoT medical device manufacturers and healthcare providers are increasingly encouraged to invest in and adopt these technologies.

Restraint:

High deployment cost of connected medical devices

Integrating IoT technology into healthcare infrastructure requires substantial investment in device procurement, data management, and cybersecurity measures. These costs can be a barrier, especially for smaller healthcare facilities and resource-constrained regions. Additionally, ongoing maintenance and updates further increase the total cost of ownership. While IoT medical devices offer substantial benefits, including improved patient care and reduced healthcare expenses in the long term, the initial financial burden can impede their widespread adoption.

Opportunity:

Evolution of high-speed networking technologies

Advancements like 5G and low-latency, high-bandwidth networks enable seamless and real-time communication between medical devices and healthcare systems. This opens up new possibilities for remote patient monitoring, telemedicine, and data-intensive applications in healthcare. Healthcare providers can access patient data rapidly and accurately, enhancing diagnostic precision and treatment planning. Moreover, high-speed networking facilitates the secure and efficient transfer of medical data, ensuring patient privacy and regulatory compliance.

Threat:

Concerns related to data management and interoperability

Developing user-friendly and ergonomic PCUs that seamlessly integrate with the seat actuation system is a complex task. Ensuring intuitive controls, safety features, and compatibility with the overall cabin design demands significant engineering expertise. Additionally, strict aviation regulations and certification processes further challenge manufacturers. Overcoming these restraints requires investments in research and development to create efficient and reliable PCUs that enhance the overall passenger experience without compromising safety and compliance standards.

COVID-19 Impact:

The healthcare industry is directly impacted by COVID-19 since it is at the forefront of this unprecedented worldwide pandemic issue. The COVID-19 outbreak has caused the demand for IoMT devices to expand rapidly, which has therefore had an effect on the global market. Due to the increase of applications and opportunities, the pandemic is acting as a catalyst for digital transformation. Government agencies, healthcare providers, and people all had to adjust or modify their priorities as a result. Despite the limitations presented by the epidemic, linked gadgets have allowed people to monitor their health, receive virtual diagnoses, and manage it more effectively.

The vital signs monitoring system segment is expected to be the largest during the forecast period

The vital signs monitoring system segment is expected to have lucrative growth, offering real-time tracking and analysis of essential physiological parameters like heart rate, blood pressure, temperature, and oxygen levels. These IoT devices enable continuous remote monitoring of patients, both in clinical settings and at home, providing healthcare professionals with immediate access to crucial data. They play a pivotal role in early disease detection, chronic condition management, and post-operative care, enhancing patient outcomes and reducing hospital readmissions.

The stationary medical device segment is expected to have the highest CAGR during the forecast period

The stationary medical device segment is anticipated to witness the fastest CAGR growth during the forecast period. These devices, integrated with IoT technology, enable real-time monitoring, data collection, and remote management of patient information. Examples include IoT-connected MRI machines, X-ray equipment, and laboratory analyzers. They streamline data transmission, enhance diagnostic accuracy, and enable healthcare professionals to monitor patients more efficiently. Stationary medical devices offer advantages such as improved treatment precision and reduced human error, contributing to better patient outcomes and the overall efficiency of healthcare delivery within institutional settings.

Region with largest share:

North America holds a significant share in the IoT Medical Devices Market, driven by its advanced healthcare infrastructure, strong research and development capabilities, and supportive regulatory environment. The region boasts a high adoption rate of IoT-enabled medical devices, including wearable health trackers and remote monitoring systems, as healthcare providers seek to improve patient care and outcomes. North America's investment in telemedicine and data-driven healthcare, along with its focus on patient-centric care models, positions it as a frontrunner in leveraging IoT technology to transform and enhance the delivery of healthcare services.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, fuelled by expanding population, increasing healthcare needs, and growing adoption of digital technologies. With the support of government initiatives and a growing tech-savvy consumer base, IoT medical devices are rapidly gaining acceptance. In addition to improving patient care, they address challenges like remote patient monitoring in rural areas. Asia Pacific's vast market potential, coupled with its commitment to healthcare innovation, positions it as a significant player in the global IoT Medical Devices Market, fostering transformative advancements in healthcare delivery.

Key players in the market:

Some of the key players in IoT Medical Devices Market include: Honeywell Life Care Solutions, IBM Corporation, iHealth Lab, Cerner Corporation, Cisco Inc, GE Healthcare, Stanley Healthcare, Welch Allyn, Abbott Laboratories, AdhereTech, AgaMatrix, AliveCor, BioTelemetry, Biotronik, Boston Scientific, Capsule Technologies, Inc, Siemens, Medtronic, Meru Health, Omron, Philips, SAP affiliate company, Johnson & Johnson, Koninklijke Philips N.V. and LifeFuels Inc.

Key Developments:

In May 2023, Medtronic (Ireland) acquired EOFlow Co. Ltd. (South Korea) to expand the company's ability to treat patients with diabetes.

In April 2023, Koninklijke Philips N.V. (Netherlands) and Northwell Health (US) partnered to assist the health system in standardizing patient monitoring, improving patient care, and improving patient outcomes while promoting interoperability and data innovation.

In March 2023, Abbott (US) acquired Cardiovascular Systems, Inc. (CSI) (US) to gains a complementary treatment option for vascular illness. The most advanced atherectomy technology from CSI prepares vessels for angioplasty or stenting to restore blood flow.

Products Covered:

  • Vital Signs Monitoring System
  • Imaging Systems
  • Implantable Cardiac Devices
  • Patient Monitors
  • Respiratory Devices
  • Infusion Pumps
  • Fetal Monitoring Devices
  • Neurological Devices
  • Ventilators
  • Anesthesia Machines
  • Hearing Devices
  • Other Products

Types Covered:

  • Wearable
  • Implantable Device
  • Stationary Medical Device
  • Other Types

Connectivity Technologies Covered:

  • Wifi
  • Bluetooth
  • Zigbee
  • Other Connectivity Technologies

Applications Covered:

  • Telemedicine
  • Medication Management
  • Patient Monitoring
  • Other Applications

End Users Covered:

  • Healthcare Providers
  • Government Authorities
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technnology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global IoT Medical Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Vital Signs Monitoring System
    • 5.2.1 Blood Pressure Monitors
    • 5.2.2 Blood Glucose Monitors
    • 5.2.3 ECG/Heart Rate Monitors
    • 5.2.4 Oximeters
    • 5.2.5 Multiparameter Monitors
  • 5.3 Imaging Systems
  • 5.4 Implantable Cardiac Devices
    • 5.4.1 Implantable Cardioverter Defibrillators
    • 5.4.2 Implantable Cardiac Monitors
  • 5.5 Patient Monitors
  • 5.6 Respiratory Devices
  • 5.7 Infusion Pumps
  • 5.8 Fetal Monitoring Devices
  • 5.9 Neurological Devices
  • 5.10 Ventilators
  • 5.11 Anesthesia Machines
  • 5.12 Hearing Devices
  • 5.13 Other Products

6 Global IoT Medical Devices Market, By Type

  • 6.1 Introduction
  • 6.2 Wearable
  • 6.3 Implantable Device
  • 6.4 Stationary Medical Device
  • 6.5 Other Types

7 Global IoT Medical Devices Market, By Connectivity Technology

  • 7.1 Introduction
  • 7.2 Wifi
  • 7.3 Bluetooth
  • 7.4 Zigbee
  • 7.5 Other Connectivity Technologies

8 Global IoT Medical Devices Market, By Application

  • 8.1 Introduction
  • 8.2 Telemedicine
  • 8.3 Medication Management
  • 8.4 Patient Monitoring
  • 8.5 Other Applications

9 Global IoT Medical Devices Market, By End User

  • 9.1 Introduction
  • 9.2 Healthcare Providers
  • 9.3 Government Authorities
  • 9.4 Other End Users

10 Global IoT Medical Devices Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Honeywell Life Care Solutions
  • 12.2 IBM Corporation
  • 12.3 iHealth Lab
  • 12.4 Cerner Corporation
  • 12.5 Cisco Inc
  • 12.6 GE Healthcare
  • 12.7 Stanley Healthcare
  • 12.8 Welch Allyn
  • 12.9 Abbott Laboratories
  • 12.10 AdhereTech
  • 12.11 AgaMatrix
  • 12.12 AliveCor
  • 12.13 BioTelemetry
  • 12.14 Biotronik
  • 12.15 Boston Scientific
  • 12.16 Capsule Technologies, Inc
  • 12.17 Siemens
  • 12.18 Medtronic
  • 12.19 Meru Health
  • 12.20 Omron
  • 12.21 Philips
  • 12.22 SAP affiliate company
  • 12.23 Johnson & Johnson
  • 12.24 Koninklijke Philips N.V.
  • 12.25 LifeFuels Inc
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦